Ciprofloxacin Tablet
NDC Package 85293-002-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Ciprofloxacin tablets is a medication used to treat a variety of bacterial infections. This formulation utilizes a tablet delivery system. Marketed by Umasuto, Llc, this product is identified by NDC 85293-002 and is authorized under FDA application ANDA076639.

Identification & Billing

NDC Package Code
85293-002-01
Package Description
100 TABLET in 1 BOTTLE
Product Code
85293-002
11-Digit Billing Format
85293000201
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Ciprofloxacin
Non-Proprietary Name
Ciprofloxacin
Substance Name
Ciprofloxacin Hydrochloride
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
CIPROFLOXACIN HYDROCHLORIDE 250 mg/1
Pharmacologic Class
Usage Information
This medication is used to treat a variety of bacterial infections. Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Regulatory & Marketing

Labeler Name
Umasuto, Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA076639
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-05-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85293-002-01 identifies a specific commercial package of 100 tablet in 1 bottle of Ciprofloxacin, a human prescription drug labeled by Umasuto, Llc. This tablet is formulated for oral use and contains ciprofloxacin hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Umasuto, Llc on March 05, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat a variety of bacterial infections. Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

How is this Umasuto, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85293000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
85293-002-01
11-Digit CMS (5-4-2)
85293-0002-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.